Triggering receptor expressed on myeloid cells-1 (TREM-1) engagement can directly trigger
inflammation or amplify an inflammatory response by synergizing with TLRs or NLRs …

Background: Converging evidence indicates prolactin (PRL) and diabetes play an important
role in the pathophysiology of cognitive impairment. However, little is known about the …

Aim Triggering receptor expressed on myeloid cells 1 (TREM‐1) and peptidoglycan
recognition protein 1 (PGLYRP1) are elevated in biofluids in the presence of various …

Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a soluble form of
TREM-1 released during inflammation. Elevated sTREM-1 levels have been found in …

Aims/hypothesis We previously demonstrated that N-glycosylation of plasma proteins and
IgGs is different in children with recent-onset type 1 diabetes compared with their healthy …

Introduction: Diabetes mellitus (DM) is a risk factor for Alzheimer's disease (AD). Increasing
evidence indicates that the triggering receptor expressed on myeloid cells (TREM)-1 …

Inflammation mediated by myeloid cells trigger receptors 1 (TREM-1) is important for
atherosclerosis development, while sirtuin 6 (Sirt6) levels decrease in atheroscleoritc …

Background and aims In-stent restenosis (ISR) remains a major limitation of percutaneous
coronary intervention despite improvements in stent design and pharmacological agents …

Type 1 diabetes (T1D) is a chronic autoimmune disease that results from destruction of
pancreatic β-cells. T1D subjects were recently shown to harbor distinct intestinal microbiome …

Background Acute myocardial infarction (AMI) is one of the fatal cardiac emergencies. The
detection of triggering receptor expressed on myeloid cells 1 (TREM1), a cell surface …